Human NK.sub.3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
US6028082A · kind A · utility
5Cited by
5References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 1998 |
| Grant date | Feb 22, 2000 |
| Priority date | — |
| Expiry date | Mar 12, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I), a method for obtaining them and pharmaceutical compositions containing them are described. The compounds are useful as human NK.sub.3 receptor antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.